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Effect of Ceratonia siliqua (Carob) syrup and vitamin E on 
sperm parameters, oxidative stress index and sex hormones in 
infertile men: Protocol for a randomized controlled trial 
 
Abstract 
Background: Spermatogenesis is a necessary process in fertility and reproductive capacity 
of humans. In view of the relative high prevalence of spermatogenesis disorders in men 
and the failure of treatments provided in conventional medicine, new therapeutic 
approaches are being considered. This study will be designed to investigate the effect of 
Ceratonia siliqua (Carob) syrup and vitamin E on sperm parameters, oxidative stress index 
and reproductive hormones in infertile men. 
Methods: This randomized controlled trial protocol will be set in Babol Uuniversity of 
Medical Sciences. The proposed sample size is 60 men with oligozoospermia and 
teratospermia with 30 men in the experimental group taking Carob syrup while 30 men in 
the comparison group receiving vitamin E. The primary outcome measure is the change in 
semen parameters and secondary outcome measures including change in endocrine 
parameters and stress oxidative markers. This research was registered in the website of 
Iranian Registry of Clinical Trials as IRCT20171209037794N1identification number 
Conclusion: If the beneficial effect of this herb can be confirmed, it will provide a cost-
effective method for helping infertile men and provide evidence-based references for the 
treatment of male infertility in future. 
Keywords: Male infertility, Ceratonia siliqua, Sperm parameters, Oxidative stress, Sex 
hormones 
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R Disorders of production of sperm during spermatogenesis process is one of the 
most common causes of male infertility. In view of the relative high prevalence of 
spermatogenesis disorders and the failure of treatments provided in conventional medicine, 
new therapeutic approaches are being considered (1). In recent years, the increasing use of 
medicinal herbs has led to extensive research on herbal medicine. Many sperm changes in 
idiopathic infertility are associated with high levels of reactive oxygen species (ROS). 
Increased production of ROS leads to oxidative damage to lipids, proteins, and cellular 
DNA. The damage to sperm’s DNA results in reduced sperm motility, acrosome 
membrane damage, and sperm disability in fertilizing oocyte (2, 3) so herbs with an 
antioxidant capacity can cope with the destructive effects of free radicals produced and the 
oxidative stress inside minimize the cell in infertile male. On the other hand, inflammation 
also reduces antioxidant’s defensive power (3). Various studies have reported that 
supplementation with antioxidants reduces inflammatory factors (4-7). One of these 
medicinal plants is Ceratonia siliqua (Carob) tree from Legominasae family which has a 
height of 7-12 meters. 
 Caspian J Intern Med 2019; 10(4):452-457  
Ceratonia siliqua and male infertility                                                                   453 
It is indigenous in the Mediterranean region, southern 
Syria, and India, as well as California, and grows widely in 
Iran, especially in Shapur, Fars and Kazeroun. This herb 
contains a lot of fibers, carbohydrates, polyphenolic 
compounds, lignin, protein, calcium, potassium phosphorus, 
glutamic acid, linolenic acid, Linoleic acid, vitamins E, D, C, 
B6, folic acid, iron, and magnesium. It is also a natural 
source of antioxidants of which its anti-oxidant activity is 
related to tannin and phenol compounds (8-11). 
It is traditionally used to increase sperm count (8, 12). 
Animal studies showed that using the extract of this herb 
have influences on cAMP production and activity of 
enzymes involved in rat's testicular steroidogenesis. In these 
researches, the use of Carob extract improved sperm quality, 
increased testosterone levels and biochemical parameters by 
affecting leydig cells and biosynthesis of testosterone, so is 
effective on sex hormones, sperm production, and 
spermatogenesis process (8, 11). The major mechanisms 
behind these effects are unknown. There have been no 
controlled human clinical trials to evaluate the effects of 
Ceratonia silique on spermatogenesis in infertile men. 
However, it is used locally in many countries.  No side 
effects have been reported for the use of this herb (fruit, 
capsule, or extract) .Researchers have reported no particular 
complications and have declared that its consumption is 
permitted in humans (12, 13). Based on our knowledge, 
human studies have not investigated the effects of this herbal 
extract on sperm parameters, oxidative stress indices, and the 
level of reproductive hormones or the results have not yet 
been published. Given the fact that there are still problems in 
the treatment of male infertility in new medicine, and given 
that in recent years, herbal medicine has been widely used as 
complementary medicine, the present study was designed to 
investigate the effect of Ceratonia siliqua syrup and vitamin 
E on sperm parameters, oxidative stress index and 
reproductive hormones in infertile men.  
 
 
Methods  
Study design: The protocol of this randomized controlled 
trial study has been approved by the Institutional Review 
Board of Babol University of Medical Sciences 
(IR.MUBABOL.HRI.REC.1396.179).  
Study setting: This study will be conducted at the Infertility 
and Reproductive Health Center affiliated to Babol 
University of Medical Sciences and at the urology clinic.  
Sample size: The trial is powered to detect an effect size of 
d ≥0.70 as statistically significant in a two-tailed test with 
α=0.05 and power of 0.80 with N=26 per condition. As there 
is the possibility that some patients do not complete the 
study, we will include 30 patients in Carob and vitamin E 
groups. 
Participants: Male partners of couples attending the 
infertility center of Babol University of Medical Sciences 
will be included in the study. The proposed sample size is 60 
men with teratospermia and oligozoospermia with 30 men in 
the experimental group taking Carob syrup and 30 men in 
the comparison group and receiving vitamin E.  
Eligibility criteria: The eligibility of each included subject 
will be confirmed by the urologist. Patients eligible for the 
trial must comply with all of the following at randomization: 
 20-45 years of age, who had complained of infertility for at 
least 12 months, and had no history of surgical or medical 
treatments for infertility. 
 Having a BMI less than 30. 
 Uncertain oligo-spermatozoa due to WHO criteria (sperm 
concentration less than 15 million per ml, type A motility 
less than 25%, and type B mobility Less than 50%, normal 
morphology less than 15%). 
 Not smoking, drinking alcohol, and addiction to substance.  
 Lack of systemic illness diseases, such as diabetes and 
thyroid disease, cerebrovascular disease and had no history 
of chemotherapy. 
 Naturally occurring gonadotropins, testosterone and 
prolactin  
 Lack of history of vasectomy or obstructive azoospermia.  
 Patients with recurrent or residual varicocele, and history of 
cryptorchidism or Azoospermia and chromosomal 
abnormalities such as kleinfelter's Syndrome are not enrolled 
in the study. 
Exclusion Criteria: 
 Genital tract infection. 
 The use of antioxidant supplements in the last three months 
and during the study. 
 The use of chemical drugs during the study. 
 Having severe physical activity.  
 Hypogonadism or pituitary abnormalities. 
Recruitment: In the run-in phase of the study, a member of 
the research team (reproductive health researcher) and 
urologist present at Fatemezahra Infertility Clinic 3 days in a 
week. The investigators will inform the participants of all 
aspects pertaining to participation in the study and will 
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screen all the patients for the eligibility criteria at the time of 
admission. Subjects` screening will be continued until the 
target population is achieved.  Participants will be free to 
withdraw any time during the study, and this will not affect 
their clinical treatment. 
Pre-randomization data: At the initial visit, baseline 
clinical demographics and a complete medical history will be 
obtained through a clinical interview, including age, 
occupation, body mass index, cigarette use, alcohol intake, 
medical history, drug history and a working clinical 
diagnosis. A physical examination will be performed in all 
who have a disorder in the number, motility or morphology 
of the sperm to identify any potentially eligible infertile men 
for the study. The criteria for choosing patients with 
disorders in terms of sperm count (oligospermia) abnormal 
morphology (teratospermia) and reduced sperm motility 
(asthenospermia) as well as the statistical results of the 
semen analysis are based on the WHO criteria (14). After the 
urologist determines that the patient is eligible for 
recruitment, all eligible participants will be asked to sign a 
written consent form before being enrolled in the study. 
Blinding: The researchers performing and analyzing data 
from the semen samples, endocrine tests, and biomarker 
analysis (outcomes assessor) will be blinded to the 
participant grouping.  
Allocation (method & allocation concealment 
mechanism): The block randomization method will be used 
to randomize patients into groups that result in equal sample 
sizes to ensure a balance across groups over time. 
Before initiation of the run- in phase of the study, two 
60- sets of random numbers will be created by a member of 
the research team not involved in recruitment. 15 blocks with 
size of 4 and combination of A for the carob and B for 
vitamin E group will be prepared. 
Allocation sequence will be password-protected and only 
accessible to the reproductive health researcher. She folds 
two times the paper containing 4-size blocks, put them in the 
standard thick envelopes and writes the serial numbers on 
them. All of the envelope will be kept at the recruitment 
center. Thus, for every eligible patient, the researcher 
randomly selects one of the envelopes after shuffling and 
assign subjects into intervention and comparison group. 
Data collection: After physical examination and check 
baseline characteristic data and eligibility criteria, semen 
analysis and hormonal status, including serum follicle-
stimulating hormone (FSH), prolactin, luteinizing hormone 
(LH), total testosterone and total antioxidant capacity (TAC) 
and malondialdehyde (MDA) will be done at baseline and 3 
months after enrollment. 
The semen samples will be collected in the privacy of a 
room near the laboratory after three days of sexual 
abstinence and kept at 37°C. A validated and standard 
laboratory (Fatemezahra Infertility Center) will be used for 
collection and analyses of the semen. Sperm characteristics 
will be studied on fresh samples immediately after 
collection. After liquefaction seminal fluid at room 
temperature, routine semen analyses including semen 
volume, concentration, sperm motility and morphology will 
be performed according to WHO recommendation (14).  
Blood samples will be centrifuged and serum will be 
stored at -50°C for metabolomics biomarkers that include 
oxidative stress index and sex hormones. Measuring the sex 
hormones is done by ELISA method and according to 
instruction of the related kit. 
Participant timeline: The time schedule of enrolment, 
interventions, and assessments based on SPIRIT 2013 
template (15) has been shown in Table 1. 
 
Table 1: SPIRIT 2013 schedule of enrolment, 
interventions, and assessments 
  Study period 
 Enrolment Allocation Post 
allocation 
Close- 
out 
Time point -t1 0 t1 t2 t3 tx 
Enrolment X      
Eligibility screen X      
Informed consent X      
Medical history X      
Safety index X      
FSH, LH, 
Prolactin, MDA 
Testosterone,  
TAC level 
X      
Semen analyses 
Allocation 
X      
 X     
Intervention       
Carob group       
Vitamin E group   X X X  
Assessments:       
FSH,LH,Prolactin, 
MDA Testosterone,  
TAC level 
     X 
Semen analyses      X 
Adverse events   X X X X 
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Data Monitoring: Two researchers from BUMS not 
involved in the study and chosen by the university will 
monitor the data and supervise the conduct of the study. 
Intervention: Patients will be assigned (1:1) to receive 
Carob syrup twice a day or vitamin E (comparison group) 
100 mg once a day for 3 months. The Carob pods will be 
purchased from herbal market in Tehran and after 
identification and confirmation by botanist will be powdered 
and extracted by decoction in water (100 gram Carob, 
(traditional dosage) in 500 ml water). Then, after filtration, 
will be mixed with 500 ml USP syrup. Each patient will use 
15 ml of Carob syrup/day (divided ×2) (~ dosage in 
traditional medicine). For all patients, a spermogram is 
performed first. Three months after the treatment, the 
spermogram and blood samples were taken from the two 
groups. The main consequence of the study is to improve the 
spermogram test and the secondary outcome of each of the 
parameters of prolactin, FSH, TAC, MDA and testosterone. 
During the initial visit where recruitment of the study occurs, 
the participants will be prescribed the medication. It is 
initially prescribed for two weeks. One week later, a 
telephone interview will be conducted to review the side 
effects and arrange an early appointment with the patient’s 
request. Two weeks later, the patient will received the 
remaining medications and adherence to treatment will be 
assessed (Figure 1). 
Follow-up: Participants will be monitored monthly for signs 
or symptoms of adverse effects. One month later, the 
participants will be reviewed in the clinic and a possible side 
effect check list will be conducted. To prevent attrition and 
to assess adherence to treatment, telephone interviews will be 
conducted again at 2 months from administration of the drug. 
3 months after intervention and upon completion of the drugs, all 
participants will be checked in the infertility clinic, semen 
analysis will be performed according to the standard clinic 
protocols for the sperm count, motility and morphology and 
serum samples will also be collected in order to evaluate markers 
of oxidative stress and reproductive hormones (Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of the study
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Adherence: Self-assessment patient’s checklist will be used 
to assess adherence to treatment, also participants will 
instruct to bring their Carob syrup bottle each visit. 
Outcome measures: The primary outcome measure will be 
the change in semen parameters after 3 months in men who 
were receiving Carob syrup compared to men who were 
taking vitamin E. Primary outcome measure according to 
(WHO) methodologies. 
 [Time frame: Before treatment and after 3 months 
treatment were finished in 2 treatment arms, semen analysis 
will be performed].  
1) sperm concentration, 2) percent motility, 3) sperm 
morphology Secondary outcome measures will include the 
change in endocrine parameters, stress oxidative markers and 
assessment of the adherence to treatment. 
1. Changes in serum levels of reproductive hormones after 
treatment ( Time frame: Before treatment and after  3 month 
treatments were finished in 2 treatment arms, reproductive 
hormones will be performed) Serum concentrations of 
follicle-stimulating hormone, luteinizing hormone, total 
testosterone and prolactin. 
2. Evaluate the level change of oxidative stress biomarkers 
in Serum (Time frame: Before treatment and after 3 months 
treatment were finished in 2 treatment arms, oxidative stress 
biomarkers will be performed) Serum concentrations of 
Malondialdehyde (MDH) and total antioxidant capacity (TAC) 
using spectrophotometer at 532 nm. 
3. Self-assessment patient’s checklist will be used to assess 
adherence to treatment. Reasons for dropping out and non-
compliance will also be noted and reported. 
Statistics and data-analysis: Baseline characteristics will be 
compared between Carob and vitamin E groups using chi-
squared tests for categorical variables and independent t-test 
for the normally distributed continuous variables. If the 
assumptions for normality are violated, then non-parametric 
techniques will be applied. One-way analysis of covariance 
(ANCOVA) will be used to evaluate treatment effects of 
Carob. Relative associations among parameters will be 
determined by Pearson’s correlation coefficient. All 
statistical analyses will be conducted using SPSS (Version 
16) software. A p-value of less than 0.05 (two-sided) indicates a 
statistically significant difference, with 95% confidence intervals. 
 
 
Discussion 
Over the past decade, diagnosis of male reproductive 
performance has progressed dramatically. Many infertile 
men have disorders treatable with medication that can be 
eliminated, if properly diagnosed and treated, which will 
allow natural fertilization. Currently, 60% of the world’s 
population use herbal drugs for treatment of diseases and 
25% of physician’s prescriptions include herbal compounds 
that have less adverse effects than other drugs. Infertility is 
one of the medical issues of couples and according to the 
World Health Organization (WHO), 10% of couples are 
affected with this problem, of which 10% to 40-50% are 
related to male factor, the most important is the low quality 
of sperm. Therefore, paying attention to eliminating these 
disorders is very important for treatment of couples 
‘infertility. There are numerous medicinal herbs with anti-
fertility and fertilizing effects in the world. These herbs have 
been used throughout the history to decrease or increase 
fertility in men. Many people now use herbal medicines or 
their derivatives to increase fertility and sexual desire. Thus, 
it is necessary to study the herbal biologically active 
substance on male fertility and natural herbal substances 
with estrogenic and anti-estrogenic properties (5). The WHO 
has reported that despite the increasing use of herbal 
medicines, there is still significantly insufficient research 
information, while the role of articles that examine the herbs 
is very important. Considering the clarification of adverse 
effects of chemical drugs on human, women and men have 
increasingly tended toward using herbal drugs. Herbal drugs 
are an appropriate substitute for normal drugs. 
This is the first study to compare the changes in sperm 
parameters after two different interventions: the active 
intervention (Carob) and vitamin E intervention. If 
successful, this study will provide new knowledge on 
preferred procedures for helping men and couples to 
conceive and offer guidance to urologists treating these men. 
List of abbreviations: 
Reactive oxygen species (ROS) 
Ceratonia Siliqua (Carob) 
Cyclic AMP (CAMP) 
Body mass index (BMI) 
Follicle-stimulating hormone (FSH) 
Luteinizing hormone (LH),  
Total antioxidant capacity (TAC)  
 Malondialdehyde (MDA) 
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